Sanyou Biopharmaceuticals

Sanyou Biopharmaceuticals is a leader in reagents and innovative biologics R&D services, offering a one-stop solution for drug research, development and manufacturing. Our mission is to make R&D easy for innovative biologics by bridging drug R&D with full lifecycle manufacturing through our 4C business model: differentiated CRO, integrated CDO, innovative CPO, and characteristic CRS. With ISO 9001 quality assurance and GB/T intellectual property management certifications, we ensure the highest quality standards and fully safeguard our clients interests. For more information, visit: www.sanyoubio.com crs.sanyoubio.com

Antibody drug,drug discovery,r&d,cro,cdmo,antibody library,phage display,antibody engineering,antibody affinity maturation,antibody humanization,in vitro efficacy screening,in vivo efficacy evaluation,gmp cell line development,fermentation process development,purification process development,high throughput screening,antigen production,antibody-drug conjugates (adc) ,bispecific antibody,and nanobody

Sanyou biopharmaceuticals operates in the Biotechnology research industry.

Sanyou biopharmaceuticals's revenue is 11m - 100m

Sanyou biopharmaceuticals has 51 - 200 employees.